Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis

By Lee Eun-Ha  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 11-25

Springer Publishing Company

Access to resources Recommend Favorite

IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis

By Cheng Hong-Bin   Yue Wu   Xie Chen   Zhang Ru-You   Hu Shao-Shan   Wang Zhi  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3555-3559

Springer Publishing Company

Access to resources Recommend Favorite

IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy

By                    

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1325-1336

Spandidos Publications

Access to resources Recommend Favorite

Comparative study of IDH1 mutations in gliomas by high resolution melting analysis, immunohistochemistry and direct DNA sequencing

By                

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4376-4381

Spandidos Publications

Access to resources Recommend Favorite

Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China

By Zhang Chuan-Bao   Bao Zhao-Shi   Wang Hong-Jun   Yan Wei   Liu Yan-Wei   Li Ming-Yang   Zhang Wei   Chen Ling   Jiang Tao  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 45-51

Springer Publishing Company

Access to resources Recommend Favorite